CIK 0001743881 · Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,563,798
- in 3 filings, $4.6M under 10b5-1 plans
Net −$4,563,798. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-19 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −602 | $72.80 | $44K | 234,451 |
| 2026-02-17 | Apuli Maricel Chief Accounting Officer | Sale 10b5-1 | −510 | $74.31 | $38K | 123,945 |
| 2026-02-17 | Trimarchi Thomas President and CFO | Sale 10b5-1 | −13,400 | $74.71 | $1.0M | 336,785 |
| 2026-02-17 | Trimarchi Thomas President and CFO | Sale 10b5-1 | −200 | $75.38 | $15K | 336,585 |
| 2026-02-17 | Scott Randal W. Director | Option exercise 10b5-1 | +10,000 | $16.75 | $168K | 21,589 |
| 2026-02-17 | Scott Randal W. Director | Sale 10b5-1 | −1,900 | $74.34 | $141K | 19,689 |
| 2026-02-17 | Scott Randal W. Director | Sale 10b5-1 | −4,793 | $75.57 | $362K | 14,896 |
| 2026-02-17 | Scott Randal W. Director | Sale 10b5-1 | −3,307 | $75.93 | $251K | 11,589 |
| 2026-02-17 | Scott Randal W. Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 31,501 | ||
| 2026-02-16 | Kumar Neil Chief Executive Officer | Option exercise | +33,544 | 262,320 | ||
| 2026-02-16 | Kumar Neil Chief Executive Officer | Option exercise | +19,600 | 281,920 | ||
| 2026-02-16 | Kumar Neil Chief Executive Officer | Option exercise | +11,554 | 293,474 | ||
| 2026-02-16 | Kumar Neil Chief Executive Officer | Shares withheld for taxes | −30,970 | $75.25 | $2.3M | 262,504 |
| 2026-02-16 | Kumar Neil Chief Executive Officer | Option exercise · Restricted Stock Units | −33,544 | 134,176 | ||
| 2026-02-16 | Kumar Neil Chief Executive Officer | Option exercise · Restricted Stock Units | −19,600 | 156,794 | ||
| 2026-02-16 | Kumar Neil Chief Executive Officer | Option exercise · Restricted Stock Units | −11,554 | 138,645 | ||
| 2026-02-16 | Apuli Maricel Chief Accounting Officer | Shares withheld for taxes 10b5-1 | −4,349 | $75.25 | $327K | 124,455 |
| 2026-02-16 | Trimarchi Thomas President and CFO | Shares withheld for taxes 10b5-1 | −18,819 | $75.25 | $1.4M | 350,185 |
| 2026-02-11 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −7,806 | $70.69 | $552K | 687,880 |
| 2026-02-11 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −3,716 | $71.44 | $265K | 684,164 |
Page 9 of 19 · 373 trades